-
Exploring common application and reactant citation problems
We recently talked in depth about what makes a really good antibody citation, and...September 10, 2018 -
Abcam’s shares receive mixed opinions
Just a few weeks ago we reported that equity research organisation Berenberg had changed...September 5, 2018 -
We ask you – what do you want to see next?
Here at CiteAb our team is busy looking at new ways we can make...August 24, 2018 -
Putting the spotlight on our new distributor widget users
Have you seen the CiteAb widget in action? Recently we’ve set up the widget...August 20, 2018 -
CiteAb data helps put Abcam back on Berenberg’s buy list
After being downgraded just three months ago by equity research organisation Berenberg, Abcam has...August 9, 2018 -
Santa Cruz maintain position in secondary antibody market
If you’ve followed our blog for a while you’ll know we like to make...August 2, 2018 -
What makes an exceptional validation programme?
In just two months we are going to be welcoming many of you to...July 26, 2018 -
We’ve launched a new biochemical search!
This week our team has launched a brand new CiteAb service, a free-to-use biochemical...July 20, 2018 -
Which were the leading antibodies of 2017?
Today we’re looking at the data we collated for antibody citations throughout the whole...July 12, 2018 -
Should you reconsider your ‘go-to’ chemical probe?
Do you have a tendency to go back to the chemical probe you know...July 11, 2018 -
Outstanding speaker line up for Antibody Validation 2018
There are just two days left to secure your place to hear our fantastic...June 27, 2018 -
CiteAb Award Winner: Focus on Diagenode
This week we’re giving you the rundown on CiteAb Innovative Product of the Year...June 22, 2018
